ChemicalBook > CAS DataBase List > 8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione

8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione

8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione Structure
8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione
  • CAS No.853029-57-9
  • Chemical Name:8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione
  • CBNumber:CB72535826
  • Molecular Formula:C20H17BrN6O2
  • Formula Weight:453.29
  • MOL File:853029-57-9.mol
8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione Property
  • Melting point >255°C (dec.)
  • Boiling point 602.9±65.0 °C(Predicted)
  • Density 1.55
  • storage temp. under inert gas (nitrogen or Argon) at 2-8°C
  • solubility DMSO (Slightly, Heated, Sonicated), Methanol (Very Slightly, Heated, Sonicated)
  • pka 2.34±0.50(Predicted)
  • form Solid
  • color White to Pale Yellow
Hazard and Precautionary Statements (GHS)
  • Symbol(GHS)
  • Signal word
  • Hazard statements
  • Precautionary statements

8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione Chemical Properties,Usage,Production

  • Uses 8-Bromo-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione is an intermediate used to prepare selective inhibitors of dipeptidyl peptidase 4 (DPP4) for potential use in the treatment of type 2 diabetes.
8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione Preparation Products And Raw materials
Raw materials
Preparation Products
8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione Suppliers
Global(277)Suppliers
  • Supplier：
    Capot Chemical Co.,Ltd.
  • Tel：+86-（0）57185586718<br/>+86-13336195806
  • Email：sales@capot.com
  • Country：China
  • ProdList：29730
  • Advantage：60
  • Supplier：
    Henan Tianfu Chemical Co.,Ltd.
  • Tel：+86-0371-55170693<br/>+86-19937530512
  • Email：info@tianfuchem.com
  • Country：China
  • ProdList：21628
  • Advantage：55
  • Supplier：
    career henan chemical co
  • Tel：+86-0371-86658258<br/>+8613203830695
  • Email：sales@coreychem.com
  • Country：China
  • ProdList：29859
  • Advantage：58
8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione Spectrum
853029-57-9, 8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dioneRelated Search:
  • 853029-57-9
  • Intermediates
  • 抑制剂
  • 化学试剂
  • 医药原料
  • 原料药
  • 043-利格列汀
  • 044-利格列汀
  • 外
  • 系列1
  • 杂质对照品
  • 糖尿病
  • 对照品-杂质对照品
  • 中间体
  • 医药中间体，医药原料，精细化工品。
  • 医药中间体
  • 利拉利汀中间体
  • 利格列汀杂质
  • C20H17BrN6O2
  • 化合物 8-BROMO-7-(BUT-2-YN-1-YL)-3-METHYL-1-((4-METHYLQUINAZOLIN-2-YL)METHYL)-1H-PURINE-2,6(3H,7H)-DIONE
  • 8-溴-7-(2-丁炔基)-3-甲基-1-((4-甲基喹唑啉-2-基)甲基)-黄嘌呤
  • 8-溴-7-(丁-2-炔-1-基)-3-甲基-1-[(4-甲基喹唑啉-2-基)甲基]-3,7-二氢-1H-嘌呤-2,6-二酮
  • 1-[(4-甲基-2-喹唑啉基)甲基]-3-甲基-7-(2-丁炔-1-基)-8-溴-3,7-二氢-1H-嘌呤-2,6-二酮
  • 利格列汀溴代物
  • 8-溴-7-(2-丁炔)-3-甲基-1-((4-甲基喹唑啉-2-基)甲基)-黄瞟呤
  • 利拉利汀杂质48
  • 利拉列汀母核
  • 利拉利汀母
  • 利格列汀杂质LINA05
  • 利格列汀杂质94
  • 利拉利汀中间体,8-溴-7-(2-丁炔-1-基)- 3,7-二氢-3-甲基-1-[(4-甲 基-2-喹唑啉基)甲基]-1H- 嘌呤-2,6-二酮
  • 8-溴-7-(2-丁炔-1-基)-3,7-二氢-3-甲基-1-[(4-甲基-2-喹唑基)甲基]-1H-嘌呤-2,6-二酮
  • 8-溴-7-(2-丁炔-1-基)-3,7-二氢-3-甲基-1-((4-甲
  • 利拉利汀杂质32
  • 利拉列汀母核(利拉列汀中间体)
  • 8-溴-7-(2-丁炔-1-基)-3,7-二氢-3-甲基-1-[(4-甲基-2-喹唑啉基)甲
  • 利格列汀杂质32
  • 利拉利汀目核
  • 8-溴-7-(2-丁炔)-3-甲基-1-((4-甲基喹唑啉-2-基)甲基)-黄嘌呤
  • 8-溴-7-(2-丁炔-1-基)-3,7-二氢-3-甲基-1-[(4-甲基-2-喹唑啉基)甲基]-1H-嘌呤-2,6-二酮 利拉利汀母核
  • 8-溴-7-(2-丁炔-1-基)-3,7-二氢-3-甲基-1-[(4-甲基-2-喹唑啉基)甲基]-1H-嘌呤-2,6-二酮
  • 利拉利汀中间体F
  • 8-溴-7-(2-丁炔-1-基)-1-[(4-甲基-2-喹唑啉基)甲基]-3-甲基黄嘌呤
  • 8-溴-7-(2-丁炔-1-基)-3,7-二氢-3-甲基-1-[(4-甲基-2-喹唑啉基)甲基]-1H-嘌呤-2,6-二酮 利拉利汀母核 1KG
  • 8-溴-7-(2-丁炔基)-3-甲基-1-((4-甲基喹唑啉-2-基)甲基)-1H-嘌呤-2,6(3H,7H)-二酮
  • 8-溴-7-丁炔-3-甲基-1-(4-甲基-喹唑啉-2-甲基)-3,7-二氢-嘌呤-2,6-二酮
  • 8-溴-7-(2-丁炔-1-基)-3,7-二氢-3-甲基-1-[(4-甲基-2-喹唑基)甲基]-1H-嘌呤-2,6-二酮9
  • 利拉利汀中间体1
  • 853029-57-9
  • LIP-1A IMPURITY
  • 8-Bromo-7-but
  • 8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-xanthine
  • Linagliptin Related Compound-11 (Bromo compound)
  • 8-Bromo-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dion
  • Linagliptin intermediate 1-[(4-methylquinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-bromoxanthine
  • 8-brom-7- (2-butynyl-1-yl) -3,7-dihydro-3-methyl-1- [(4-methyl-2-quinazolino) methyl] -1H-purine-2,6-dione
  • 1-[(4-Methylquinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl) 8-bromoyanthine
  • 8- bromo -7-(2- butyn -1- yl) -3,7- dihydro -3- methyl -1-[(4- methyl -2- quinazolinyl) methyl ]-1H- purin -2,6- dione

Home

My